<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE589CCE-4366-4CEE-883A-CC75CF6E58D8"><gtr:id>CE589CCE-4366-4CEE-883A-CC75CF6E58D8</gtr:id><gtr:name>Cincinnati Children's Hospital Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/867D7150-5A9C-40BF-9572-8D58FD26F76E"><gtr:id>867D7150-5A9C-40BF-9572-8D58FD26F76E</gtr:id><gtr:name>Institute of Genetic and Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE589CCE-4366-4CEE-883A-CC75CF6E58D8"><gtr:id>CE589CCE-4366-4CEE-883A-CC75CF6E58D8</gtr:id><gtr:name>Cincinnati Children's Hospital Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A919B771-5C0F-4AD1-B747-03D25677DC3B"><gtr:id>A919B771-5C0F-4AD1-B747-03D25677DC3B</gtr:id><gtr:name>University of Texas Southwestern Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/867D7150-5A9C-40BF-9572-8D58FD26F76E"><gtr:id>867D7150-5A9C-40BF-9572-8D58FD26F76E</gtr:id><gtr:name>Institute of Genetic and Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8B42480C-C16B-45BD-A61E-FCB97FD77B2C"><gtr:id>8B42480C-C16B-45BD-A61E-FCB97FD77B2C</gtr:id><gtr:name>RIKEN</gtr:name><gtr:address><gtr:line1>1-7-22, Suehiro-cho</gtr:line1><gtr:line2>Tsurumi-ku</gtr:line2><gtr:line4>Yokohama</gtr:line4><gtr:line5>Kanagawa 230-0045</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E80CF82D-EF99-4480-9D13-F12A0B7E8363"><gtr:id>E80CF82D-EF99-4480-9D13-F12A0B7E8363</gtr:id><gtr:firstName>Llewelyn</gtr:firstName><gtr:surname>Roderick</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F0000H215"><gtr:id>ED2DB5DD-997C-489E-9864-3123A9746B3C</gtr:id><gtr:title>Investigation into the role of inositol 1,4,5-triphosphate mediated calcium release in controlling cardiac hypertrophy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/0000H215</gtr:grantReference><gtr:abstractText>Heart disease is a significant cause of mortality in the developed world. In 2004 it was responsible for 137,700 deaths in the UK, equating to 24 percent of all deaths. A major predictor of mortality due to heart disease is cardiac hypertrophy (an increase in cell size without increase in cell number), and it is the most important risk factor for heart failure in humans. Hypertrophy can however also be a beneficial adaptive response providing the increased blood supply required during pregnancy and to sustain levels of increased physical activity experienced by athletes. Cardiac hypertrophy is characterised by an increase in the muscle mass/size of the heart due to enlargement of heart cells without any proliferation. Calcium increases in the muscle cells of the heart control contraction and the activity of genes that determine heart size. Since during disease the heart can grow too much, causing it not to work so well and fail, it is important to understand how calcium can precisely regulate the genes' activity and heart contraction. Using microsocopy and molecular biology techniques, we will measure changes in cell calcium and gene activity associated with heart growth. The effect of modifying calcium changes upon heart growth will also be monitored. Using these approaches, we aim to understand how calcium can precisely control myocyte (muscle cell) transcription (the copying of DNA information into RNA) independent of its effects on contraction. Ultimately, drugs will be developed to control heart growth without affecting heart function.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2007-09-17</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>146816</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>RIKEN</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>RIKEN Brain Science Institute</gtr:department><gtr:description>MIkoshiba</gtr:description><gtr:id>A60145E0-07B5-4407-8C11-571F1DAA9E92</gtr:id><gtr:impact>Publication in JCB: 23166348
Publication in Mol Cell: 19250908</gtr:impact><gtr:outcomeId>oPaCaRJPmB1-1</gtr:outcomeId><gtr:partnerContribution>Provision of IP3R2 monoclonal antibody.

Provision of heart tissue from IP3R2 KO animals</gtr:partnerContribution><gtr:piContribution>Analysis of tissue from itpr2 KO animals
Use of IP3R2 monoclonal Antibody</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Institute for Experimental Medical Research</gtr:department><gtr:description>Norway Rats</gtr:description><gtr:id>06015564-AEAE-4EAC-99F3-13DE837E1011</gtr:id><gtr:impact>Publication in JCB in 2012
27893464
23166348</gtr:impact><gtr:outcomeId>EH4BuwbJM5e-1</gtr:outcomeId><gtr:partnerContribution>Provision and phenotyping of hearts hypertrophic due to exercise, aortic banding or ageing.</gtr:partnerContribution><gtr:piContribution>Analysis of Cardiac Myocyte proteome, transcriptome and epigenome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas Southwestern Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>UT SW</gtr:description><gtr:id>97FC291A-A186-48D0-A82A-37D4A7924AD4</gtr:id><gtr:impact>Publication in JCB in 2012: 23166348</gtr:impact><gtr:outcomeId>DDV4Q15V7vx-1</gtr:outcomeId><gtr:partnerContribution>Provision of tissue and mRNA from miR-133 double knockout animals</gtr:partnerContribution><gtr:piContribution>Analysis of Tissue from miR-133 DKO animals</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Ritter</gtr:description><gtr:id>7F01FD6B-A0BC-4B83-A3EF-FF801C9D7A8C</gtr:id><gtr:impact>Publication in Mol Cell: 19250908
Publication in PNAS: 19549843</gtr:impact><gtr:outcomeId>q8tG7GuDDkX-1</gtr:outcomeId><gtr:partnerContribution>Provision of tissue from surgically prepared mice.
Provision of cell permeant peptide.
Provision of GFP-tagged calcineurin expression vectors.</gtr:partnerContribution><gtr:piContribution>Analysis of Cardiac tissue from aortically constricted mice.

Analysis of effect of cell permeant peptide that prevents calcineurin nuclear import upon NFAT accumulation in the nucleus.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Genetic and Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Catalucci</gtr:description><gtr:id>544DBC91-41D6-491C-A504-739E8A665F1E</gtr:id><gtr:impact>23166348</gtr:impact><gtr:outcomeId>otu9drHzbxj-1</gtr:outcomeId><gtr:partnerContribution>Provision of hearts from mice injected with miRNA inhibitor.</gtr:partnerContribution><gtr:piContribution>Analysis of effect of micro RNA on heart growth</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Conway</gtr:description><gtr:id>1CC0AED4-5143-4321-A018-495C705CC822</gtr:id><gtr:impact>23166348
20106523
19934645
19549843
19250908
18407350
18250332
17692540
17585817
17574672
16882691
16814379
15561771
15263017
14685260
12767897</gtr:impact><gtr:outcomeId>UAaNvHyGCrr-1</gtr:outcomeId><gtr:partnerContribution>Provision of Cell permeant IP3 analogues</gtr:partnerContribution><gtr:piContribution>USe and testing of cell permeant IP3 analogues</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cincinnati Children's Hospital Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pediatrics</gtr:department><gtr:description>Molkentin</gtr:description><gtr:id>E134D3EF-F1AC-4C2D-936B-4E0B633A09B1</gtr:id><gtr:impact>Publication in Journal of Cell Biology in 2012
23166348</gtr:impact><gtr:outcomeId>V3rccksHAFw-1</gtr:outcomeId><gtr:partnerContribution>The collaborator provided hearts from control and aortically constricted mice transgenic for the IP3R Ligand binding domain and for type 2 IP3 receptors.</gtr:partnerContribution><gtr:piContribution>Analysed the mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Heart Failure 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0C869905-CC33-4244-819C-23A0EA47615B</gtr:id><gtr:impact>Heart Failure 2012, April 2012, Belgrade
http://www.escardio.org/congresses/hf2012/pages/welcome.aspx
Oral Presentation
Abstract title: IP3 induced calcium release engages a pro-hypertrophic autoamplifying loop that relieves miR-133a mediated suppression of IP3RII
Authors: FM Drawnel, D Wachten, JD Molkentin, I Sjaastad, N Liu, MD Bootman and HL Roderick.

The data was discussed and new directions for the research considered.</gtr:impact><gtr:outcomeId>aPkXrpWiAPP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>3.	June 2013. Calcium Signalling Gordon Research Conference. Il Ciocco. Italy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EED0D0C0-66B3-4264-8F4A-20102CB8E6B2</gtr:id><gtr:impact>200 Participants.

Valuable interactions subsequent</gtr:impact><gtr:outcomeId>Cx5gwFrEF5n</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2.	September 2013. Cambridge-Yale Cardiovascular Meeting, Yale, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>39639E0E-709A-410A-B74C-250BB91B430F</gtr:id><gtr:impact>Interacted with clinicians and scientists from Yale and Cambridge
50 attendees at meeting.


Useful interactions made that may progress to formal collaborations.</gtr:impact><gtr:outcomeId>UzNyCCdEfRL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Biochemical Society meeting 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D1ACC24-DE18-4025-8E3C-1714C535A281</gtr:id><gtr:impact>Talk provoked interest and discussions. 


Possible collaborations initiated</gtr:impact><gtr:outcomeId>547dd17e68eef3.22171439</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>472485</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Research Foundation - Flanders (FWO)</gtr:fundingOrg><gtr:fundingRef>G08861N</gtr:fundingRef><gtr:id>F700E440-B78B-4551-A403-8C5F64B7F2FD</gtr:id><gtr:outcomeId>56e01847112199.41278168</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>837974</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Odysseus FWO</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Research Foundation - Flanders (FWO)</gtr:fundingOrg><gtr:fundingRef>90663</gtr:fundingRef><gtr:id>285186EA-7BED-4E52-9238-A52681046C56</gtr:id><gtr:outcomeId>56e01771321a58.41791742</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>That nuclear localised increases in calcium could be interpreted by the cardiac myocyte separate from the increase in calcium that control contraction to induce cardiac growth. 
We also found that these calcium changes coming from IP3 receptor channels could act to alter the amount of IP3 receptors. This not being by switching on the gene but by controlling a small RNA called a microRNA that could regulate how much protein was made from the IP3R mRNA.</gtr:description><gtr:exploitationPathways>By identifying some of the mechanism by which gene expression required for the cardiac growth during disease is controlled, we have found a new way to treat heart disease.</gtr:exploitationPathways><gtr:id>9BCCED74-98D7-4D03-8908-2FE089A0385E</gtr:id><gtr:outcomeId>56e161a680b0c4.62286932</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>17578233-2E51-4548-8640-156648FB4454</gtr:id><gtr:title>Atrial cardiomyocyte calcium signalling.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca46a32ad353fd2426ddafcbbf11ce5"><gtr:id>8ca46a32ad353fd2426ddafcbbf11ce5</gtr:id><gtr:otherNames>Bootman MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_5435b105b10a8634a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54BA907-BF38-4E8D-8743-46103FDEF062</gtr:id><gtr:title>The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68c2e68d3718a5f66984a8c761f7b093"><gtr:id>68c2e68d3718a5f66984a8c761f7b093</gtr:id><gtr:otherNames>Drawnel FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_16328_28_22946456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B82736FA-2016-4EC9-BBDC-259E8924DE6D</gtr:id><gtr:title>Excitation-Contraction Coupling</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34d475652eef687d979cc7d1b43c0d50"><gtr:id>34d475652eef687d979cc7d1b43c0d50</gtr:id><gtr:otherNames>Smyrnias I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-3-540-36065-0</gtr:isbn><gtr:outcomeId>Jf7xHx2DJJz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B76D38F-F88C-4763-97F7-2AA6D719A16A</gtr:id><gtr:title>Inositol 1,4,5-trisphosphate receptors: &amp;quot;exciting&amp;quot; players in cardiac excitation-contraction coupling?</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32a0b7feede55be1c898ac1aa35fd4d5"><gtr:id>32a0b7feede55be1c898ac1aa35fd4d5</gtr:id><gtr:otherNames>Roderick HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_16328_28_23983251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86CB6869-57B0-4CC4-902C-778371DAD61B</gtr:id><gtr:title>Comparison of the T-tubule system in adult rat ventricular and atrial myocytes, and its role in excitation-contraction coupling and inotropic stimulation.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34d475652eef687d979cc7d1b43c0d50"><gtr:id>34d475652eef687d979cc7d1b43c0d50</gtr:id><gtr:otherNames>Smyrnias I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>pm_16328_28_20106523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50FF586B-71A3-4EA4-A23C-6672465088B8</gtr:id><gtr:title>Handbook of Cell Signaling</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725d1cc52ff8f4ed32a0e2170aafcef"><gtr:id>4725d1cc52ff8f4ed32a0e2170aafcef</gtr:id><gtr:otherNames>Harzheim D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>58cebfe663a0e2.46741905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AA71562-C888-4285-B0F1-36BAC39674AB</gtr:id><gtr:title>Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68c2e68d3718a5f66984a8c761f7b093"><gtr:id>68c2e68d3718a5f66984a8c761f7b093</gtr:id><gtr:otherNames>Drawnel FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_16328_28_23166348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFE46A7E-B70F-4663-9BAE-C902E5EDF20D</gtr:id><gtr:title>Why, where, and when do cardiac myocytes express inositol 1,4,5-trisphosphate receptors?</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Heart and circulatory physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ca46a32ad353fd2426ddafcbbf11ce5"><gtr:id>8ca46a32ad353fd2426ddafcbbf11ce5</gtr:id><gtr:otherNames>Bootman MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0363-6135</gtr:issn><gtr:outcomeId>pm_16328_18_18065525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0A31A33-AD96-48B4-B75D-D598B37EB181</gtr:id><gtr:title>Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38fb548c5d0f24302ac28b406d12d4cd"><gtr:id>38fb548c5d0f24302ac28b406d12d4cd</gtr:id><gtr:otherNames>Kocksk?mper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>pm_16328_18_18603259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>785245C5-C993-425E-9549-CB0C775CCB0B</gtr:id><gtr:title>Calcium in the heart: when it's good, it's very very good, but when it's bad, it's horrid.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32a0b7feede55be1c898ac1aa35fd4d5"><gtr:id>32a0b7feede55be1c898ac1aa35fd4d5</gtr:id><gtr:otherNames>Roderick HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56e00a465ab3f6.50185782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E17BAB41-639F-4CDB-9776-11D3B21D0F6F</gtr:id><gtr:title>Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Channels (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4725d1cc52ff8f4ed32a0e2170aafcef"><gtr:id>4725d1cc52ff8f4ed32a0e2170aafcef</gtr:id><gtr:otherNames>Harzheim D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1933-6950</gtr:issn><gtr:outcomeId>pm_16328_18_19934645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E46A7A1-DA35-4A3C-9FD5-5299113307DC</gtr:id><gtr:title>Calcium signaling in cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7e2beba954e5fb8c50851d9226bc7b"><gtr:id>da7e2beba954e5fb8c50851d9226bc7b</gtr:id><gtr:otherNames>Fearnley CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn><gtr:outcomeId>pm_16328_28_21875987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E627948-B3A0-4CBC-82FB-6AB2F724E64E</gtr:id><gtr:title>Endothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a7836353946728cf65878119368bd2e"><gtr:id>0a7836353946728cf65878119368bd2e</gtr:id><gtr:otherNames>Higazi DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_16328_18_19250908</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/0000H215</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>